Ann D. Rhoads, Director at GLOBUS MEDICAL INC (GMED), sold 7,500 shares at $78.68 ($590K) on 2025-02-28, disclosed to the SEC on 2025-03-04.
Scheduled sale ($590k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GMED | SELL | 2025-09-16 | $585K | — | Filing → |
| GMED | SELL | 2024-09-17 | $1.1M | — | Filing → |
| RPTX | BUY | 2020-06-25 | $80K | — | Filing → |